BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 33890276)

  • 21. The impact of medical and recreational marijuana laws on opioid prescribing in employer-sponsored health insurance.
    Wen J; Wen H; Butler JS; Talbert JC
    Health Econ; 2021 May; 30(5):989-1000. PubMed ID: 33624387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and internal validation of a prediction model for long-term opioid use-an analysis of insurance claims data.
    Held U; Forzy T; Signorell A; Deforth M; Burgstaller JM; Wertli MM
    Pain; 2024 Jan; 165(1):44-53. PubMed ID: 37782553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization of Counseling Services by Pediatric Patients With Obesity Using MarketScan Data (2017-2019).
    Rajbhandari-Thapa J; Chung SR; Hu H; Hall DB; Tiwari BB
    Child Obes; 2023 Dec; 19(8):570-574. PubMed ID: 36413350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vision Screening Among Children With Private Insurance: 2010-2019.
    Oke I; Lutz SM; Hunter DG; Galbraith AA
    Pediatrics; 2023 Sep; 152(3):. PubMed ID: 37605872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States.
    Shen C; Thornton JD; Li N; Schaefer E; Zhou S; Kawasaki S; Pameijer C; Leslie D
    Oncologist; 2024 Feb; 29(2):176-184. PubMed ID: 37944042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of methods to identify individuals prescribed opioid analgesics for pain.
    Farjo R; Hu HM; Waljee JF; Englesbe MJ; Brummett CM; Bicket MC
    Reg Anesth Pain Med; 2024 Jan; ():. PubMed ID: 38272570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of Cryptococcosis Among Patients With Commercial Health Insurance and Patients With Medicaid, United States, 2016-2022.
    Benedict K; Smith DJ; Gold JAW
    Open Forum Infect Dis; 2024 May; 11(5):ofae260. PubMed ID: 38798897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction to: Benzodiazepine, Z-drug, and sleep medication prescriptions in male and female people with opioid use disorder on buprenorphine and comorbid insomnia: an analysis of multistate insurance claims.
    Sleep; 2023 Dec; 46(12):. PubMed ID: 37815241
    [No Abstract]   [Full Text] [Related]  

  • 29. Gabapentin as Adjunctive Therapy in Neonatal Opioid Withdrawal Syndrome: A Case Series.
    Patz C; Liviskie C; Bird M; Zeller B; Vesoulis ZA; Smyser CD; McPherson C
    J Pediatr Pharmacol Ther; 2023; 28(4):368-373. PubMed ID: 37795276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration and Timing of In Utero Opioid Exposure and Incidence of Neonatal Withdrawal Syndrome.
    Wang Y; Berger L; Durrance C; Kirby RS; Kuo D; Pac J; Ehrenthal DB
    Obstet Gynecol; 2023 Sep; 142(3):603-611. PubMed ID: 37548391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997-2018.
    Werler MM; Kerr SM; Ailes EC; Reefhuis J; Gilboa SM; Browne ML; Kelley KE; Hernandez-Diaz S; Smith-Webb RS; Garcia MH; Mitchell AA;
    Clin Pharmacol Ther; 2023 Oct; 114(4):836-844. PubMed ID: 37356083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of diagnostic codes for prenatal opioid exposure and neonatal opioid withdrawal syndrome.
    Kuzniewicz MW; Campbell CI; Li S; Walsh EM; Croen LA; Comer SD; Pimentel SD; Hedderson M; Sun LS
    J Perinatol; 2023 Mar; 43(3):293-299. PubMed ID: 36131095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentially Problematic Opioid Prescriptions Among Individuals With Private Insurance and Medicaid.
    Ali MM; Tehrani AB; Mutter R; Henke RM; O'Brien M; Pines JM; Mazer-Amirshahi M
    Psychiatr Serv; 2019 Aug; 70(8):681-688. PubMed ID: 31056003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-acting and Long-acting Opioids Utilization among Women Diagnosed with Endometriosis in the United States: A Population-based Claims Study.
    As-Sanie S; Soliman AM; Evans K; Erpelding N; Lanier RK; Katz NP
    J Minim Invasive Gynecol; 2021 Feb; 28(2):297-306.e2. PubMed ID: 32531340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Claims-based measures of prescription opioid utilization: A practical guide for researchers.
    Heins SE; Buttorff C; Armstrong C; Pacula RL
    Drug Alcohol Depend; 2021 Nov; 228():109087. PubMed ID: 34598101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid prescription claims among women aged 15-44 years-United States, 2013-2017.
    Summers AD; Ailes EC; Bohm MK; Tran EL; Broussard CS; Frey MT; Gilboa SM; Ko JY; Lind JN; Honein MA
    J Opioid Manag; 2021; 17(2):125-133. PubMed ID: 33890276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017.
    Mikosz CA; Zhang K; Haegerich T; Xu L; Losby JL; Greenspan A; Baldwin G; Dowell D
    JAMA Netw Open; 2020 May; 3(5):e204514. PubMed ID: 32391892
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.